Concepts (110)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prostatic Neoplasms | 3 | 2019 | 794 | 0.520 |
Why?
|
| Health Status Disparities | 1 | 2019 | 583 | 0.460 |
Why?
|
| Breast Neoplasms | 2 | 2019 | 1426 | 0.410 |
Why?
|
| Chalcone | 1 | 2010 | 5 | 0.390 |
Why?
|
| Chalcones | 1 | 2010 | 13 | 0.390 |
Why?
|
| Neurites | 1 | 2010 | 35 | 0.380 |
Why?
|
| Cell Proliferation | 1 | 2010 | 1149 | 0.260 |
Why?
|
| Basement Membrane | 1 | 2019 | 28 | 0.180 |
Why?
|
| Cell Adhesion Molecules | 1 | 2019 | 70 | 0.170 |
Why?
|
| Genetic Variation | 2 | 2019 | 328 | 0.170 |
Why?
|
| Silver | 1 | 2019 | 53 | 0.170 |
Why?
|
| Immunity, Innate | 1 | 2019 | 135 | 0.170 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2019 | 91 | 0.170 |
Why?
|
| Extracellular Matrix | 1 | 2018 | 111 | 0.160 |
Why?
|
| Drug Delivery Systems | 1 | 2018 | 182 | 0.150 |
Why?
|
| Metal Nanoparticles | 1 | 2019 | 180 | 0.140 |
Why?
|
| Receptors, Steroid | 1 | 2015 | 33 | 0.130 |
Why?
|
| Antineoplastic Agents | 2 | 2018 | 756 | 0.130 |
Why?
|
| Hepatocytes | 1 | 2015 | 74 | 0.130 |
Why?
|
| Inflammation | 1 | 2019 | 577 | 0.130 |
Why?
|
| Gene Expression Regulation | 1 | 2019 | 968 | 0.120 |
Why?
|
| Toll-Like Receptor 6 | 1 | 2013 | 2 | 0.120 |
Why?
|
| Ethanol | 1 | 2015 | 188 | 0.120 |
Why?
|
| Cathepsins | 2 | 2004 | 6 | 0.120 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2013 | 25 | 0.120 |
Why?
|
| Liver | 1 | 2015 | 447 | 0.110 |
Why?
|
| Lysosomes | 3 | 2004 | 80 | 0.110 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2013 | 638 | 0.110 |
Why?
|
| Chlorofluorocarbons, Methane | 1 | 2010 | 1 | 0.100 |
Why?
|
| Butadienes | 1 | 2010 | 30 | 0.100 |
Why?
|
| Culture Media, Serum-Free | 1 | 2010 | 40 | 0.100 |
Why?
|
| PC12 Cells | 1 | 2010 | 84 | 0.100 |
Why?
|
| Nitriles | 1 | 2010 | 66 | 0.090 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2010 | 109 | 0.090 |
Why?
|
| Flavonoids | 1 | 2010 | 78 | 0.090 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2013 | 528 | 0.090 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2010 | 117 | 0.090 |
Why?
|
| United States | 1 | 2019 | 3894 | 0.090 |
Why?
|
| Enzyme Precursors | 3 | 2004 | 10 | 0.080 |
Why?
|
| Humans | 9 | 2019 | 34853 | 0.080 |
Why?
|
| Models, Biological | 1 | 2010 | 642 | 0.080 |
Why?
|
| Cell Line | 1 | 2010 | 1289 | 0.070 |
Why?
|
| Cysteine Endopeptidases | 2 | 2004 | 57 | 0.070 |
Why?
|
| Male | 4 | 2019 | 18870 | 0.070 |
Why?
|
| Apoptosis | 2 | 2012 | 1317 | 0.070 |
Why?
|
| Camptothecin | 1 | 2003 | 20 | 0.060 |
Why?
|
| I-kappa B Proteins | 1 | 2003 | 38 | 0.060 |
Why?
|
| Rats | 1 | 2010 | 3261 | 0.060 |
Why?
|
| Female | 2 | 2019 | 19873 | 0.060 |
Why?
|
| Cell Line, Tumor | 2 | 2019 | 2128 | 0.050 |
Why?
|
| Glioma | 1 | 2003 | 76 | 0.050 |
Why?
|
| Up-Regulation | 1 | 2004 | 490 | 0.050 |
Why?
|
| Animals | 4 | 2015 | 14307 | 0.050 |
Why?
|
| Fibroblasts | 1 | 2002 | 252 | 0.050 |
Why?
|
| NF-kappa B | 1 | 2003 | 306 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2013 | 1056 | 0.040 |
Why?
|
| Cathepsin D | 1 | 1998 | 15 | 0.040 |
Why?
|
| Aged, 80 and over | 2 | 2013 | 2333 | 0.040 |
Why?
|
| Alcohol Dehydrogenase | 1 | 2015 | 8 | 0.030 |
Why?
|
| Cytochrome P-450 CYP2E1 | 1 | 2015 | 14 | 0.030 |
Why?
|
| Liver Diseases, Alcoholic | 1 | 2015 | 7 | 0.030 |
Why?
|
| Aldehyde Dehydrogenase | 1 | 2015 | 14 | 0.030 |
Why?
|
| Cyclin D1 | 1 | 2015 | 42 | 0.030 |
Why?
|
| Lipid Peroxidation | 1 | 2015 | 131 | 0.030 |
Why?
|
| Estrogen Receptor alpha | 1 | 2015 | 105 | 0.030 |
Why?
|
| Sex Characteristics | 1 | 2015 | 213 | 0.030 |
Why?
|
| Interferon Regulatory Factor-3 | 1 | 2013 | 2 | 0.030 |
Why?
|
| Interleukin-1 Receptor-Associated Kinases | 1 | 2013 | 6 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2015 | 608 | 0.030 |
Why?
|
| Cathepsin L | 2 | 2004 | 13 | 0.030 |
Why?
|
| Entropy | 1 | 2012 | 10 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2013 | 184 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2012 | 269 | 0.030 |
Why?
|
| Transfection | 2 | 2003 | 496 | 0.030 |
Why?
|
| Aged | 2 | 2013 | 6448 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2012 | 171 | 0.020 |
Why?
|
| Alcohol Drinking | 1 | 2015 | 490 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2015 | 1530 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2012 | 245 | 0.020 |
Why?
|
| Cell Line, Transformed | 2 | 2002 | 87 | 0.020 |
Why?
|
| Mice | 2 | 2015 | 5668 | 0.020 |
Why?
|
| Logistic Models | 1 | 2012 | 894 | 0.020 |
Why?
|
| Middle Aged | 2 | 2013 | 9642 | 0.020 |
Why?
|
| Endosomes | 1 | 2004 | 34 | 0.020 |
Why?
|
| Transport Vesicles | 1 | 2004 | 20 | 0.020 |
Why?
|
| Risk Factors | 1 | 2012 | 3414 | 0.020 |
Why?
|
| Carmustine | 1 | 2003 | 1 | 0.010 |
Why?
|
| Carboplatin | 1 | 2003 | 13 | 0.010 |
Why?
|
| Adenoviridae | 1 | 2003 | 59 | 0.010 |
Why?
|
| Protein Transport | 1 | 2004 | 286 | 0.010 |
Why?
|
| Drug Synergism | 1 | 2003 | 171 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 2003 | 164 | 0.010 |
Why?
|
| Receptor, IGF Type 2 | 1 | 2002 | 7 | 0.010 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 2002 | 4 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 2002 | 58 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2002 | 39 | 0.010 |
Why?
|
| Microsomes | 1 | 2002 | 52 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2003 | 480 | 0.010 |
Why?
|
| ras Proteins | 1 | 2002 | 49 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2002 | 186 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2002 | 116 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2003 | 325 | 0.010 |
Why?
|
| Repressor Proteins | 1 | 2003 | 226 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2002 | 834 | 0.010 |
Why?
|
| Saposins | 1 | 1998 | 10 | 0.010 |
Why?
|
| Intracellular Membranes | 1 | 1998 | 34 | 0.010 |
Why?
|
| Paclitaxel | 1 | 1998 | 48 | 0.010 |
Why?
|
| Glycoproteins | 1 | 1998 | 100 | 0.010 |
Why?
|
| Time Factors | 1 | 2002 | 1681 | 0.010 |
Why?
|
| Binding Sites | 1 | 1998 | 597 | 0.010 |
Why?
|